MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma.

Saved in:
Bibliographic Details
Title: MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma.
Authors: Yoshida S; Department of Pediatrics, University of California, Davis, Sacramento, CA, USA; Department of Pediatrics, Niigata University, Japan., Duong C; Department of Pediatrics, University of California, Davis, Sacramento, CA, USA., Oestergaard M; Ionis Pharmaceuticals, Carlsbad, CA, USA., Fazio M; Ionis Pharmaceuticals, Carlsbad, CA, USA., Chen C; Department of Pediatrics, University of California, Davis, Sacramento, CA, USA., Peralta R; Ionis Pharmaceuticals, Carlsbad, CA, USA., Guo S; Ionis Pharmaceuticals, Carlsbad, CA, USA., Seth PP; Ionis Pharmaceuticals, Carlsbad, CA, USA., Li Y; Department of Public Health Sciences, University of California, Davis, Sacramento, CA, USA., Beckett L; Department of Public Health Sciences, University of California, Davis, Sacramento, CA, USA., Nitin N; Departments of Food Science & Technology and Biological & Agricultural Engineering, University of California, Davis, Davis, CA, USA., Satake N; Department of Pediatrics, University of California, Davis, Sacramento, CA, USA. Electronic address: nsatake@ucdavis.edu.
Source: Nanomedicine : nanotechnology, biology, and medicine [Nanomedicine] 2020 Feb; Vol. 24, pp. 102127. Date of Electronic Publication: 2019 Nov 26.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101233142 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-9642 (Electronic) Linking ISSN: 15499634 NLM ISO Abbreviation: Nanomedicine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1549-9642
DOI:10.1016/j.nano.2019.102127